Atypical and uncommon CT and MR imaging presentations of pancreatic ductal adenocarcinoma
- PMID: 33914139
- DOI: 10.1007/s00261-021-03089-6
Atypical and uncommon CT and MR imaging presentations of pancreatic ductal adenocarcinoma
Abstract
Pancreatic ductal adenocarcinomas (PDACs) occasionally have atypical and uncommon imaging presentations that can present a diagnostic dilemma and result in false interpretation. This article aimed to illustrate these CT and MR imaging findings, including isoattenuating PDAC, coexisting acute pancreatitis, PDAC with a cystic feature, groove PDAC, diffuse PDAC, hypointensity on diffusion-weighted imaging (DWI), multifocal PDAC, intratumoral calcification, and extrapancreatic invasion with a barely discernable mass. A subset of PDACs with atypical features are occasionally encountered during routine clinical practice. Knowledge of and attention to these atypical and uncommon variable imaging features may allow radiologists to avoid misinterpretation and a delayed diagnosis.
Keywords: CT; Imaging; MR; Pancreatic ductal adenocarcinoma.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.BMC Med Imaging. 2021 Oct 15;21(1):149. doi: 10.1186/s12880-021-00679-0. BMC Med Imaging. 2021. PMID: 34654379 Free PMC article.
-
Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.Eur Radiol. 2017 Apr;27(4):1722-1732. doi: 10.1007/s00330-016-4522-0. Epub 2016 Aug 10. Eur Radiol. 2017. PMID: 27510628
-
Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation.Cancer Imaging. 2020 Jul 23;20(1):52. doi: 10.1186/s40644-020-00324-z. Cancer Imaging. 2020. PMID: 32703312 Free PMC article. Review.
-
Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.Clin Imaging. 2019 May-Jun;55:132-139. doi: 10.1016/j.clinimag.2019.02.013. Epub 2019 Feb 20. Clin Imaging. 2019. PMID: 30818163
-
Pancreatitis and PDAC: association and differentiation.Abdom Radiol (NY). 2020 May;45(5):1324-1337. doi: 10.1007/s00261-019-02292-w. Abdom Radiol (NY). 2020. PMID: 31705251 Review.
Cited by
-
Development and validation of a nomogram model based on ultrasound and contrast-enhanced ultrasound features for differentiating mass-forming pancreatitis and pancreatic ductal adenocarcinoma.Abdom Radiol (NY). 2025 May 31. doi: 10.1007/s00261-025-05035-2. Online ahead of print. Abdom Radiol (NY). 2025. PMID: 40448846
-
The Cuff sign.Abdom Radiol (NY). 2023 May;48(5):1862-1864. doi: 10.1007/s00261-023-03816-1. Epub 2023 Feb 8. Abdom Radiol (NY). 2023. PMID: 36752857 No abstract available.
-
Diagnostic accuracy of apparent diffusion coefficient to differentiate intrapancreatic accessory spleen from pancreatic neuroendocrine tumors.World J Gastrointest Oncol. 2023 Jun 15;15(6):1051-1061. doi: 10.4251/wjgo.v15.i6.1051. World J Gastrointest Oncol. 2023. PMID: 37389113 Free PMC article.
-
Morphological characterization of atypical pancreatic ductal adenocarcinoma with cystic lesion on DCE-CT: a comprehensive retrospective study.BMC Med Imaging. 2025 Mar 14;25(1):87. doi: 10.1186/s12880-025-01586-4. BMC Med Imaging. 2025. PMID: 40087584 Free PMC article.
-
Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ultrasound.Quant Imaging Med Surg. 2023 Jun 1;13(6):3902-3914. doi: 10.21037/qims-22-1132. Epub 2023 Apr 24. Quant Imaging Med Surg. 2023. PMID: 37284072 Free PMC article.
References
-
- Al-Hawary MM, Francis IR, Chari ST, Fishman EK, Hough DM, Lu DS, et al. Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology. 2014;270(1):248-60. https://doi.org/10.1148/radiol.13131184 . - DOI - PubMed
-
- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Pancreatic Adenocarcinoma. Version 2.2021. https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf (2021). Accessed Mar 23, 2021.
-
- Kim JH, Park SH, Yu ES, Kim MH, Kim J, Byun JH, et al. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257(1):87-96. https://doi.org/10.1148/radiol.10100015 . - DOI - PubMed
-
- Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB, Jr. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology. 2002;224(3):764-8. https://doi.org/10.1148/radiol.2243011284 . - DOI - PubMed
-
- Ishigami K, Yoshimitsu K, Irie H, Tajima T, Asayama Y, Nishie A, et al. Diagnostic value of the delayed phase image for iso-attenuating pancreatic carcinomas in the pancreatic parenchymal phase on multidetector computed tomography. European journal of radiology. 2009;69(1):139-46. https://doi.org/10.1016/j.ejrad.2007.09.012 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical